Attenuated Listeria Monocytogenes Bacteria
Attenuated Listeria Monocytogenes Bacteria Uses, Dosage, Side Effects, Food Interaction and all others data.
Attenuated Listeria Monocytogenes Bacteria is under investigation in clinical trial NCT02853604 (Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer).
| Trade Name | Attenuated Listeria Monocytogenes Bacteria |
| Generic | Axalimogene filolisbac |
| Axalimogene filolisbac Other Names | Adxs hpv, Live, attenuated listeria monocytogenes bacteria, expressing human papilloma virus type 16-e7 tumor antigen, Raligize |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Attenuated Listeria Monocytogenes Bacteria
